Tracking Response to Antidepressants in Advance of Investigational Trials
(TRAIT Trial)
Recruiting in Palo Alto (17 mi)
SE
Overseen byStephanie Ellickson, PhD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Adams Clinical
No Placebo Group
Trial Summary
What is the purpose of this trial?
TRAIT is an open-label observational study to evaluate treatment response to selective-serotonin reuptake inhibitors (SSRIs) and selective-norepinephrine reuptake inhibitors (SNRIs) among individuals meeting criteria for Major Depressive Disorder (MDD) and seeking enrollment in investigational trials.
Research Team
SE
Stephanie Ellickson, PhD
Principal Investigator
Adams Clinical
Eligibility Criteria
Inclusion Criteria
Participant has signed an ICF prior to any study-specific procedures being performed.
Participant is male or female of age ≥ 18 years old.
Participant has a diagnosis of MDD as confirmed by the MINI semi-structured diagnostic interview and ≥ 14 HAM-D total score.
See 1 more
Treatment Details
Interventions
- Selective-norepinephrine reuptake inhibitors (SNRIs) (Selective Norepinephrine Reuptake Inhibitor)
- Selective-serotonin reuptake inhibitors (SSRIs) (Selective Serotonin Reuptake Inhibitor)
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Adams ClinicalWatertown, MA
Loading ...
Who Is Running the Clinical Trial?
Adams Clinical
Lead Sponsor
Trials
5
Patients Recruited
3,100+